+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Trial of Tanderil in prevention and therapy of thrombo-embolic accidents Study session on thrombo-embolic disease, Paris-UNESCO, 15 December, 1963



Trial of Tanderil in prevention and therapy of thrombo-embolic accidents Study session on thrombo-embolic disease, Paris-UNESCO, 15 December, 1963



ANN ANESTH FRANC 5-(Spec no ): 171-176



Preliminary good results in 13 patients indicate the value of the anti-inflammatory effect of oxyphenbutazone in both prophylaxis and therapy of thrombo-embolic postoperative complications. This adjuvant agent may be used with antibiotics, anti-inflammatory hormones or local antiphlogistic ointments which currently are used. Oxyphenbutazone reinforces the action of a microbial lysate, Lantigen B. Mechanism of action through activation of blood proteases in different ways by these 2 agents are discussed.

(PDF emailed within 1 workday: $29.90)

Accession: 026014705

Download citation: RISBibTeXText


Related references

Trial of Lantigen B for prevention of thrombo-embolic accidents Study session on thrombo-embolic disease, Paris-UNESCO, 15 December, 1963. ANN ANESTH FRANC 5(Spec no ): 157-158, 1964

Prevention of thrombo-embolic diseases Study session on thrombo-embolic disease, Paris-UNESCO, 15 December, 1963 Discussion, on fat-metabolism and arteriosclerosis. ANN ANESTH FRANC 5(Spec no ): 137-140, 1964

Prevention of thrombo-embolic disease in general surgery Study session on thrombo-embolic disease, Paris-UNESCO, 15 December, 1963. ANN ANESTH FRANC 5(Spec no ): 141-145, 1964

Individualized prevention of thrombo-embolic disease by a complete anticoagulant treatment based on thromboelastograph results Study session on thrombo-embolic disease, Paris-UNESCO, 15 December, 1963. ANN ANESTH FRANC 5(Spec no ): 161-165, 1964

Place of the laboratory in diagnosis and therapy of thrombo-embolic disease Study session on thrombo-embolic disease, Paris-UNESCO, 15 December, 1963 Discussion. ANN ANESTH FRANC 5(Spec no ): 111-116, 1964

Development of thrombo-embolic disease therapies with streptokinase Study session on thrombo-embolic disease, Paris-UNESCO, 15 December, 1963 Discussion. ANN ANESTH FRANC 5(Spec no ): 205-206, 1964

Present concept of pathogenesis and physiopathology of thrombo-embolic disease Study session on thrombo-embolic disease, Paris-UNESCO, 15 December, 1963 A comprehensive review. ANN ANESTH FRANC 5(Spec no ): 27-63, 1964

Outline of clinical aspects of thrombo-embolic disease Study session on thrombo-embolic disease, Paris-UNESCO, 15 December, 1963. ANN ANESTH FRANC 5(Spec no ): 5-21, 1964

Some remarks on thrombo-embolic disease Study session on thrombo-embolic disease, Paris-UNESCO, 15 December, 1963 Discussion. ANN ANESTH FRANC 5(Spec, no ): 233-235, 1964

Relation of thrombo-embolic disease to some meteorologic variations in Madagascar Three-year study Study session on thrombo-embolic disease, Paris-UNESCO, 15 December, 1963. 1964

Treatment of hemorrhagic accidents from an overdose of dicoumarol derivatives Study session on thrombo-embolic disease Paris-UNESCO, 15 December, 1963. 1964

Complications of anticoagulant therapy Study session on thrombo-embolic disease, Paris-UNESCO, 15 December, 1963. ANN ANESTH FRANC 5(Spec no ): 177-179, 1964

A criterion of efficacy of heparin therapy Study session on thrombo-embolic disease, Paris-UNESCO, 15 December, 1963. ANN ANESTH FRANC 5(Spec no ): 129-133, 1964

Compressive methods in prevention and therapy of venous thromboses Bases and applications Nards method Study session on thrombo-embolic disease, Paris-UNESCO, 15 December, 1963. 1964

Study session on thrombo-embolic disease, Paris-UNESCO, 15 December, 1963. ANN AESTH FRANC 5(Spec no ): 5-259, 1964